US Stock MarketDetailed Quotes

APDN Applied DNA Sciences

Watchlist
  • 0.179
  • +0.013+7.50%
Close Dec 24 13:00 ET
  • 0.179
  • -0.001-0.34%
Post 17:01 ET
9.37MMarket Cap-0.10P/E (TTM)

Applied DNA Sciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Sep 30, 2024
(Q4)Sep 30, 2024
(Q3)Jun 30, 2024
(Q2)Mar 31, 2024
(Q1)Dec 31, 2023
(FY)Sep 30, 2023
(Q4)Sep 30, 2023
(Q3)Jun 30, 2023
(Q2)Mar 31, 2023
(Q1)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-120.52%-13.71M
-21.24%-3.25M
-155.24%-3.49M
-1,597.28%-3.21M
-57.68%-3.76M
30.74%-6.22M
17.76%-2.68M
21.95%-1.37M
181.86%214.39K
35.62%-2.38M
Net income from continuing operations
29.28%-7.09M
8.35%-3.31M
159.39%1.85M
-915.31%-4.49M
70.60%-1.13M
-21.20%-10.02M
-444.07%-3.62M
-176.87%-3.11M
131.32%551.18K
18.57%-3.84M
Operating gains losses
-760.24%-7.4M
125.78%134K
-2,180.89%-5.79M
127.56%895.97K
-200.28%-2.64M
88.38%-860.48K
89.32%-519.7K
115.83%278.4K
---3.25M
--2.63M
Depreciation and amortization
-48.88%696.43K
-76.65%76.99K
-61.57%134.16K
-45.91%186.33K
-11.79%298.95K
5.56%1.36M
0.61%329.68K
8.71%349.15K
7.37%344.5K
5.66%338.92K
Other non cash items
--650.32K
--17.13K
----
----
----
----
----
----
----
----
Change In working capital
-146.59%-1.14M
-125.23%-193.68K
-151.18%-348.66K
-98.68%30.5K
52.17%-628.05K
156.31%2.45M
401.01%767.6K
27.43%681.25K
37.02%2.31M
-29.81%-1.31M
-Change in receivables
-103.49%-106.51K
-63.00%151.86K
-108.40%-105.02K
-97.99%41.9K
71.94%-195.25K
672.48%3.05M
187.68%410.39K
561.30%1.25M
64.30%2.09M
34.55%-695.91K
-Change in inventory
-139.88%-108.57K
158.35%31.28K
-249.37%-133.93K
-62.73%41.35K
-137.74%-47.26K
-64.54%272.22K
-12.60%-53.61K
0.37%89.66K
-83.11%110.93K
80.70%125.23K
-Change in prepaid assets
-155.58%-426.73K
-394.51%-399.54K
-76.95%53.86K
-125.39%-67.33K
-110.28%-13.71K
255.67%767.81K
23.08%135.66K
-2.10%233.63K
132.42%265.15K
649.59%133.37K
-Change in payables and accrued expense
64.45%-480.44K
-94.57%15.23K
81.53%-163.57K
132.03%51.32K
34.60%-383.42K
-245.23%-1.35M
-18.46%280.6K
-875.52%-885.47K
-124.95%-160.26K
-244.86%-586.24K
-Change in other working capital
93.98%-17.65K
237.61%7.5K
--0
-490.20%-36.75K
104.00%11.6K
-203.74%-293.12K
97.19%-5.45K
-102.04%-7.41K
114.74%9.42K
-264.09%-289.68K
Cash from discontinued investing activities
Operating cash flow
-120.52%-13.71M
-21.24%-3.25M
-155.24%-3.49M
-1,597.28%-3.21M
-57.68%-3.76M
30.74%-6.22M
17.76%-2.68M
21.95%-1.37M
181.86%214.39K
35.62%-2.38M
Investing cash flow
Cash flow from continuing investing activities
62.78%-407.9K
59.85%-371.25K
86.51%-21.83K
72.71%-14.83K
0
-123.84%-1.1M
-281.05%-924.67K
-111.02%-161.8K
17.08%-54.34K
142.99%45K
Net PPE purchase and sale
-1,119.52%-407.9K
-426,824.14%-371.25K
9.80%-21.83K
72.71%-14.83K
--0
93.17%-33.45K
100.04%87
68.44%-24.2K
17.08%-54.34K
142.99%45K
Net business purchase and sale
--0
----
----
----
----
---1.06M
----
----
----
----
Cash from discontinued investing activities
Investing cash flow
62.78%-407.9K
59.85%-371.25K
86.51%-21.83K
72.71%-14.83K
--0
-123.84%-1.1M
-281.05%-924.67K
-111.02%-161.8K
17.08%-54.34K
142.99%45K
Financing cash flow
Cash flow from continuing financing activities
13.4M
-390.72K
10.81M
3.02M
-35.08K
0
0
0
0
0
Net common stock issuance
--13.4M
---390.72K
--10.81M
--2.93M
--45.57K
--0
--0
--0
--0
--0
Proceeds from stock option exercised by employees
--394
--0
----
----
----
--0
--0
----
----
----
Net other financing activities
----
----
----
----
---80.64K
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
--13.4M
---390.72K
--10.81M
--3.02M
---35.08K
--0
--0
--0
--0
--0
Net cash flow
Beginning cash position
-48.07%7.9M
-2.73%11.19M
-70.09%3.9M
-68.09%4.11M
-48.07%7.9M
132.12%15.22M
145.76%11.51M
100.18%13.04M
368.54%12.88M
132.12%15.22M
Current changes in cash
90.15%-720.71K
-11.28%-4.01M
576.32%7.29M
-230.84%-209.41K
-62.21%-3.79M
-184.45%-7.31M
-134.22%-3.6M
16.38%-1.53M
-95.75%160.05K
38.58%-2.34M
End cash Position
-9.12%7.18M
-9.12%7.18M
-2.73%11.19M
-70.09%3.9M
-68.09%4.11M
-48.07%7.9M
-48.07%7.9M
145.76%11.51M
100.18%13.04M
368.54%12.88M
Free cash flow
-124.25%-14.12M
-42.42%-3.62M
-129.69%-3.52M
-2,114.90%-3.22M
-57.68%-3.76M
33.49%-6.3M
27.40%-2.54M
16.38%-1.53M
148.88%160.05K
37.40%-2.38M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Sep 30, 2024(Q4)Sep 30, 2024(Q3)Jun 30, 2024(Q2)Mar 31, 2024(Q1)Dec 31, 2023(FY)Sep 30, 2023(Q4)Sep 30, 2023(Q3)Jun 30, 2023(Q2)Mar 31, 2023(Q1)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -120.52%-13.71M-21.24%-3.25M-155.24%-3.49M-1,597.28%-3.21M-57.68%-3.76M30.74%-6.22M17.76%-2.68M21.95%-1.37M181.86%214.39K35.62%-2.38M
Net income from continuing operations 29.28%-7.09M8.35%-3.31M159.39%1.85M-915.31%-4.49M70.60%-1.13M-21.20%-10.02M-444.07%-3.62M-176.87%-3.11M131.32%551.18K18.57%-3.84M
Operating gains losses -760.24%-7.4M125.78%134K-2,180.89%-5.79M127.56%895.97K-200.28%-2.64M88.38%-860.48K89.32%-519.7K115.83%278.4K---3.25M--2.63M
Depreciation and amortization -48.88%696.43K-76.65%76.99K-61.57%134.16K-45.91%186.33K-11.79%298.95K5.56%1.36M0.61%329.68K8.71%349.15K7.37%344.5K5.66%338.92K
Other non cash items --650.32K--17.13K--------------------------------
Change In working capital -146.59%-1.14M-125.23%-193.68K-151.18%-348.66K-98.68%30.5K52.17%-628.05K156.31%2.45M401.01%767.6K27.43%681.25K37.02%2.31M-29.81%-1.31M
-Change in receivables -103.49%-106.51K-63.00%151.86K-108.40%-105.02K-97.99%41.9K71.94%-195.25K672.48%3.05M187.68%410.39K561.30%1.25M64.30%2.09M34.55%-695.91K
-Change in inventory -139.88%-108.57K158.35%31.28K-249.37%-133.93K-62.73%41.35K-137.74%-47.26K-64.54%272.22K-12.60%-53.61K0.37%89.66K-83.11%110.93K80.70%125.23K
-Change in prepaid assets -155.58%-426.73K-394.51%-399.54K-76.95%53.86K-125.39%-67.33K-110.28%-13.71K255.67%767.81K23.08%135.66K-2.10%233.63K132.42%265.15K649.59%133.37K
-Change in payables and accrued expense 64.45%-480.44K-94.57%15.23K81.53%-163.57K132.03%51.32K34.60%-383.42K-245.23%-1.35M-18.46%280.6K-875.52%-885.47K-124.95%-160.26K-244.86%-586.24K
-Change in other working capital 93.98%-17.65K237.61%7.5K--0-490.20%-36.75K104.00%11.6K-203.74%-293.12K97.19%-5.45K-102.04%-7.41K114.74%9.42K-264.09%-289.68K
Cash from discontinued investing activities
Operating cash flow -120.52%-13.71M-21.24%-3.25M-155.24%-3.49M-1,597.28%-3.21M-57.68%-3.76M30.74%-6.22M17.76%-2.68M21.95%-1.37M181.86%214.39K35.62%-2.38M
Investing cash flow
Cash flow from continuing investing activities 62.78%-407.9K59.85%-371.25K86.51%-21.83K72.71%-14.83K0-123.84%-1.1M-281.05%-924.67K-111.02%-161.8K17.08%-54.34K142.99%45K
Net PPE purchase and sale -1,119.52%-407.9K-426,824.14%-371.25K9.80%-21.83K72.71%-14.83K--093.17%-33.45K100.04%8768.44%-24.2K17.08%-54.34K142.99%45K
Net business purchase and sale --0-------------------1.06M----------------
Cash from discontinued investing activities
Investing cash flow 62.78%-407.9K59.85%-371.25K86.51%-21.83K72.71%-14.83K--0-123.84%-1.1M-281.05%-924.67K-111.02%-161.8K17.08%-54.34K142.99%45K
Financing cash flow
Cash flow from continuing financing activities 13.4M-390.72K10.81M3.02M-35.08K00000
Net common stock issuance --13.4M---390.72K--10.81M--2.93M--45.57K--0--0--0--0--0
Proceeds from stock option exercised by employees --394--0--------------0--0------------
Net other financing activities -------------------80.64K--------------------
Cash from discontinued financing activities
Financing cash flow --13.4M---390.72K--10.81M--3.02M---35.08K--0--0--0--0--0
Net cash flow
Beginning cash position -48.07%7.9M-2.73%11.19M-70.09%3.9M-68.09%4.11M-48.07%7.9M132.12%15.22M145.76%11.51M100.18%13.04M368.54%12.88M132.12%15.22M
Current changes in cash 90.15%-720.71K-11.28%-4.01M576.32%7.29M-230.84%-209.41K-62.21%-3.79M-184.45%-7.31M-134.22%-3.6M16.38%-1.53M-95.75%160.05K38.58%-2.34M
End cash Position -9.12%7.18M-9.12%7.18M-2.73%11.19M-70.09%3.9M-68.09%4.11M-48.07%7.9M-48.07%7.9M145.76%11.51M100.18%13.04M368.54%12.88M
Free cash flow -124.25%-14.12M-42.42%-3.62M-129.69%-3.52M-2,114.90%-3.22M-57.68%-3.76M33.49%-6.3M27.40%-2.54M16.38%-1.53M148.88%160.05K37.40%-2.38M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------
Trending US Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Tesla
TSLA
+7.36%
Broadcom
AVGO
+3.15%
Netflix
NFLX
+2.27%
Amazon
AMZN
+1.77%
Cisco
CSCO
+1.48%

Unlock the Full List

Investment Theme Mpox (monkeypox)
Mpox (monkeypox)
Intraday+0.36%